![N'-[4-[4-[2-[3-[(Dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-1H-pyrazol-3-yl]phenyl]-N,N-dimethylurea structure, CAS 942918-07-2](/structures/60000/59292_1_942918_07_2.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 942918-07-2 |
| Catalog No. | 2A-9059292 |
| Chinese Name | N'-[4-[4-[2-[3-[(二甲基氨基)甲基]苯基]-1H-吡咯并[2,3-b]吡啶-4-基]-1-乙基-1H-吡唑-3-基]苯基]-N,N-二甲基脲 |
| Synonyms | GSK-1070916 |
| Molecular Formula | C30H33O1N7 |
| Molecular Weight | 507.64 |
| Purity | 98.00 |
| Density | 1.2±0.1 g/cm3 |
| Appearance | powder |
| Storage Condition | -20℃ |
| Application | GSK-1070916 is a potent, selective, ATP-competitive aurora B/C inhibitor with Ki values of 0.38 and 1.5 nM respectively. |
| MDL Number | MFCD22420815 |
| MSDS | msds/59292_1_942918_07_2.pdf |
| Transport Info | Product name: GSK1070916 |
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA